PRO-AAS EC 81 MG — DIN 02536587
ACETYLSALICYLIC ACID : 81 MG · PRO DOC LIMITEE · TABLET (DELAYED-RELEASE) · wholesale supply in Canada
Health Canada status: APPROVED
What is PRO-AAS EC?
PRO-AAS EC 81 MG contains ACETYLSALICYLIC ACID : 81 MG. It is listed in the Health Canada Drug Product Database under DIN 02536587, held by PRO DOC LIMITEE, supplied as TABLET (DELAYED-RELEASE) for ORAL administration. Health Canada currently lists it as approved, status dated 31-Mar-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
Is there a generic Acetylsalicylic Acid in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
49 holders have a Canadian DIN containing Acetylsalicylic Acid, across 146 DINs, of which 15 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAYER INC | 9 | 3 | ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH, ASPIRIN EXTRA STRENGTH, ASPIRIN EXTRA STRENGTH PLUS, ASPIRIN EXTRA STRENGTH WITH STOMACH GUARD, ASPIRIN GRANULES, +3 more | Sourceable in Canada |
| PHARMASCIENCE INC | 13 | 2 | ASA SUPPOSITORIES 150MG, ASA SUPPOSITORIES 650MG, ASAPHEN, ASAPHEN E.C. 80 MG, ASAPHEN PLUS 325, +4 more | Sourceable in Canada |
| PRO DOC LIMITEE | 6 | 2 | ASA 975 TAB, ASA-325 COMPRIMES RETARD, ASA-650 COMPRIMES RETARD, PRO-AAS - 80 (CROQUABLE), PRO-AAS EC, +1 more | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 4 | 2 | A.S.A. 325 MG TABLET, EXTRA STRENGTH ASA 500MG, JAMP-ASA CHEW, JAMP-ASA EC | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 2 | 2 | RIVASA 80MG CROQUABLE - TAB, RIVASA FC | Sourceable in Canada |
| VITA HEALTH PRODUCTS INC | 5 | 1 | ASA 325MG, ASA 80MG, ASA EXTRA STRENGTH TAB 500MG, ENTERIC COATED ASA TABLETS 325MG, ENTERIC COATED ASA TABLETS 650MG | Sourceable in Canada |
| LABORATOIRE RIVA INC. 660 Boul. Industriel Blainville Quebec Canada J7C 3V4 | 1 | 1 | RIVASA 80 MG EC | Sourceable in Canada |
| LNK INTERNATIONAL INC. | 1 | 1 | REGULAR STRENGTH ASA | Sourceable in Canada |
| MANTRA PHARMA INC | 1 | 1 | M-ASA 80 MG CROQUABLE | Sourceable in Canada |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 16 | 0 | ASA TABLETS USP 325 MG, ASADOL 325MG, ASADOL 650MG, ENTERIC COATED A.S.A, ENTERIC COATED A.S.A (CAPLET), +10 more | No marketed DIN |
| STERLING WINTHROP INC. | 9 | 0 | ASPIRIN - CHILDREN'S SIZE 80MG, ASPIRIN CHEWABLE TABLETS - 325MG, ASPIRIN COATED CAPLETS 325 MG, ASPIRIN COATED CAPLETS 500MG, ASPIRIN ENTERIC COATED CAPLET 325MG, +3 more | No marketed DIN |
| BAYER INC CONSUMER CARE | 8 | 0 | ASPIRIN - CHILDREN'S SIZE - TABLETS, ASPIRIN ARTHRITIS PAIN RELIEF 650 MG, ASPIRIN CHEWABLE TABLETS, ASPIRIN CHEWABLE TABLETS 325MG, ASPIRIN COATED FOR DELAYED RELEASE EXTRA STRENGTH, +3 more | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 81 MG |
|---|---|
| Dosage form | TABLET (DELAYED-RELEASE) |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Acetylsalicylic Acid |
|---|---|
| ATC code | N02BA01 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02536587 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2536587 |
| Brand name | PRO-AAS EC |
| Generic / active ingredient | ACETYLSALICYLIC ACID : 81 MG |
| Market authorization holder | PRO DOC LIMITEE |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N02BA01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02BA |
| Current status | APPROVED |
| Status date | 31-Mar-2023 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
15 of 146 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ASA 325MG | 325 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 00530336 |
| ASAPHEN | 80 MG | TABLET (CHEWABLE) | PHARMASCIENCE INC | MARKETED | 02009013 |
| ASAPHEN E.C. 80 MG | 80 MG | TABLET (DELAYED-RELEASE) | PHARMASCIENCE INC | MARKETED | 02238545 |
| ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH | 325 MG | TABLET (DELAYED-RELEASE) | BAYER INC | MARKETED | 02150417 |
| ASPIRIN EXTRA STRENGTH | 500 MG | TABLET | BAYER INC | MARKETED | 02150336 |
| ASPIRIN REGULAR STRENGTH | 325 MG | TABLET | BAYER INC | MARKETED | 02150328 |
| JAMP-ASA CHEW | 80 MG | TABLET (CHEWABLE) | JAMP PHARMA CORPORATION | MARKETED | 02269139 |
| JAMP-ASA EC | 80 MG | TABLET (DELAYED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | 02283905 |
| M-ASA 80 MG CROQUABLE | 80 MG | TABLET (CHEWABLE) | MANTRA PHARMA INC | MARKETED | 02429950 |
| PRO-AAS - 80 (CROQUABLE) | 80 MG | TABLET (CHEWABLE) | PRO DOC LIMITEE | MARKETED | 02311518 |
2 · Same class — other molecules in ATC N02BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Acetylsalicylic Acid | A.S.A. · A.S.A. (ACETYLSALICYLIC ACID) TAB 325MG USP · A.S.A. 325 MG TABLET · A.S.A. 80MG ACETYLSALICYLIC ACID TABLETS · +122 more | 146 | 15 | Yes |
| Acetylsalicylic Acid, Comb With Psycholeptics | 282 MEP TAB · APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE · EQUAGESIC TABLETS · FIORINAL · +9 more | 14 | 5 | Yes |
| Acetylsalicylic Acid, Comb Excl Psycholeptics | 217 · 217 STRONG TAB · ALKA SELTZER EVT · ALKA SELTZER FLAVOURED · +48 more | 54 | 0 | Not in Canada |
| Diflunisal | DIFLUNISAL · DIFLUNISAL-250 - TAB 250MG · DIFLUNISAL-500 - TAB 500MG · DOLOBID TAB 250MG · +4 more | 10 | 0 | Not in Canada |
| Salicylic Acid And Derivatives | ARTHRITEN TABLETS · BACK-ESE M TAB 325MG · BACK-ESE M TABLETS 325 MG · DOAN'S BACKACHE PILLS 325MG · +1 more | 5 | 0 | Not in Canada |
| Sodium Salicylate | DODD'S TABLETS REGULAR STRENGTH 325 MG · DODD'S TABLETS REGULAR STRENGTH 325MG · DODDS EXTRA STRENGTH TAB 500MG · DODDS PILLS | 5 | 0 | Not in Canada |
| Salicyloylsalicylic Acid | DISALCID - TAB 500MG · DISALCID - TAB 750MG · DISALCID TAB 500MG · DISALCID TAB 750MG | 4 | 0 | Not in Canada |
| Choline Salicylate, Comb. Excl Psycholeptics | TEEJEL GEL · TRILISATE TAB | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N02B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N02BE | Acetaminophen (Paracetamol) · Acetaminophen, Comb Excl Psycholeptics | 1156 | 208 |
| N02BF | Gabapentin · Pregabalin | 432 | 168 |
| N02BG | Cannabinoids · Floctafenine · Methoxyflurane | 7 | 3 |
| N02BB | Phenazone, Combinations Excl Psycholeptics | 2 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.